Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Naoe

Showing results (121-130 of 321) with videos related to

Pageof 33
Sort By:
International Journal of Hematology|October 5, 2010
Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemiaAkane Tsujimura, Hitoshi Kiyoi, Yukimasa Shiotsu, et al.
International Journal of Hematology|October 20, 2006
Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphomaJunji Hiraga, Tomohiro Kinoshita, Toshihito Ohno, et al.
Cancer Science|November 7, 2022
Clinical outcomes of second-generation tyrosine kinase inhibitors versus imatinib in older patients with CMLTakaaki Ono, Naoto Takahashi, Masahiro Kizaki, et al.
Scientific Reports|August 18, 2015
Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cellsKeiki Sugimoto, Fumihiko Hayakawa, Satoko Shimada, et al.
International Journal of Hematology|December 5, 2012
Iron chelation therapy for a case of transfusion-independent MDS-RARS with significant iron overloadHaruhiko Ohashi, Kayo Arita, Yasuhiro Suzuki, et al.
Cancer Science|June 28, 2016
SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathwayYusuke Takagi, Kazuyuki Shimada, Satoko Shimada, et al.
Plos One|December 10, 2020
In vivo tracking of transplanted macrophages with near infrared fluorescent dye reveals temporal distribution and specific homing in the liver that can be perturbed by clodronate liposomesSatoshi Nishiwaki, Shigeki Saito, Kyosuke Takeshita, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|April 25, 2008
Sustained remission after rituximab-containing chemotherapy for intravascular large B-cell lymphomaKazuyuki Shimada, Hiroshi Kosugi, Hiroto Narimatsu, et al.
Molecular and Cellular Biology|June 15, 2007
PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiationHitoshi Yoshida, Hitoshi Ichikawa, Yusuke Tagata, et al.
British Journal of Haematology|April 9, 2005
A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantationSeitaro Terakura, Makoto Murata, Tetsuya Nishida, et al.
Pageof 33

Showing results (121-130 of 321) with videos related to

Sort By:
Pageof 33
International Journal of Hematology|October 5, 2010
Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemiaAkane Tsujimura, Hitoshi Kiyoi, Yukimasa Shiotsu, et al.
International Journal of Hematology|October 20, 2006
Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphomaJunji Hiraga, Tomohiro Kinoshita, Toshihito Ohno, et al.
Cancer Science|November 7, 2022
Clinical outcomes of second-generation tyrosine kinase inhibitors versus imatinib in older patients with CMLTakaaki Ono, Naoto Takahashi, Masahiro Kizaki, et al.
Scientific Reports|August 18, 2015
Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cellsKeiki Sugimoto, Fumihiko Hayakawa, Satoko Shimada, et al.
International Journal of Hematology|December 5, 2012
Iron chelation therapy for a case of transfusion-independent MDS-RARS with significant iron overloadHaruhiko Ohashi, Kayo Arita, Yasuhiro Suzuki, et al.
Cancer Science|June 28, 2016
SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathwayYusuke Takagi, Kazuyuki Shimada, Satoko Shimada, et al.
Plos One|December 10, 2020
In vivo tracking of transplanted macrophages with near infrared fluorescent dye reveals temporal distribution and specific homing in the liver that can be perturbed by clodronate liposomesSatoshi Nishiwaki, Shigeki Saito, Kyosuke Takeshita, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|April 25, 2008
Sustained remission after rituximab-containing chemotherapy for intravascular large B-cell lymphomaKazuyuki Shimada, Hiroshi Kosugi, Hiroto Narimatsu, et al.
Molecular and Cellular Biology|June 15, 2007
PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiationHitoshi Yoshida, Hitoshi Ichikawa, Yusuke Tagata, et al.
British Journal of Haematology|April 9, 2005
A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantationSeitaro Terakura, Makoto Murata, Tetsuya Nishida, et al.
Pageof 33